Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp (NASDAQ: AHCO) operates as one of the largest home medical equipment and respiratory services providers in the United States, with operations spanning 46 states. As a publicly traded healthcare company, AdaptHealth regularly generates news across several categories that matter to investors and healthcare industry observers tracking the home medical equipment sector.
Earnings announcements represent a significant portion of AdaptHealth news coverage, with quarterly and annual results providing insight into revenue trends across the company's therapeutic segments including sleep therapy, respiratory equipment, mobility products, and wound care supplies. These financial disclosures reveal how the company navigates Medicare reimbursement rates, payor mix changes, and demand patterns for home healthcare equipment.
Partnership and acquisition news frequently emerges from AdaptHealth as the company has built its national presence through strategic growth. Announcements involving health system partnerships, regional acquisitions, or expanded service agreements signal how the company is extending its geographic reach and referral networks. These developments matter because scale provides competitive advantages in an industry with pressure on reimbursement rates.
Investor conference participation and analyst presentations offer windows into management perspectives on industry trends, including the ongoing shift toward home-based care delivery, chronic disease management outside hospitals, and the impact of healthcare policy on durable medical equipment providers. Credit rating changes and debt refinancing activities also generate news given the capital-intensive nature of equipment distribution.
Bookmark this page to follow AdaptHealth developments including earnings releases, strategic transactions, and operational updates relevant to understanding this home healthcare equipment company's trajectory.
AdaptHealth Corp. (NASDAQ: AHCO) reported its financial results for Q4 and fiscal year 2022, highlighting a net revenue increase of 21% year-over-year, reaching $3.160 billion to $3.240 billion for 2023. Despite a strong revenue growth of 11.1% in Q4, net income fell to $69.3 million, down from $156.2 million in 2021. Adjusted EBITDA in 2022 was $593.8 million, while Q4 EBITDA dropped to $146.0 million. The company aims to implement cost containment programs to align with updated guidance. CEO Steve Griggs emphasized strategic advancements, including a merger integration with AeroCare and commitment to healthcare solutions for chronic patients.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its fourth quarter and full year 2022 financial results on February 28, 2023, prior to market opening. The management team will hold a teleconference at 8:30 a.m. ET to discuss financial metrics and business activities with analysts and investors. Interested parties can join the call via phone, using the specified domestic and international numbers, or by registering for the webcast. AdaptHealth provides patient-centered healthcare-at-home solutions, including home medical equipment and supplies, serving approximately 3.9 million patients annually through a network of over 750 locations across 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) announced its initial guidance for fiscal year 2023, projecting net revenue between
AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:00 PM PT. The presentation will be available via a live webcast on the company's investor website. AdaptHealth specializes in patient-centered healthcare-at-home solutions, providing a range of medical equipment and supplies to help manage chronic conditions. The company serves approximately 3.9 million patients annually across the United States through a network of 750 locations.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the BofA Securities Home Care Conference on December 5 at 2:00 pm ET. CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will represent the company. A live webcast and replay will be available on AdaptHealth's investors page, with attendees encouraged to register early. AdaptHealth is a leading provider of healthcare-at-home solutions, serving approximately 3.9 million patients annually across 750 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) reported record net revenue of $756.5 million for Q3 2022, up 15.8% from $653.3 million in Q3 2021. However, net income dropped to $16.1 million ($0.11 per share) from $58.1 million ($0.20 per share) year-over-year. Adjusted EBITDA increased slightly to $160.2 million, while cash flow from operations rose significantly to $107.0 million. The company updated its fiscal year 2022 guidance, projecting net revenue between $2.950 billion and $3.010 billion, reflecting strong demand in the healthcare-at-home market.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its third quarter 2022 financial results before the market opens on November 8, 2022. Management will hold a teleconference at 8:30 a.m. ET to discuss the results and ongoing business activities with analysts and investors. AdaptHealth is a leader in providing healthcare-at-home solutions, serving around 3.9 million patients annually through over 750 locations in 47 states, focusing on home medical equipment, medical supplies, and related services.
AdaptHealth Corp. (NASDAQ: AHCO) announced new long-term financial goals during its 2022 Capital Markets Day. CEO Steve Griggs highlighted the company's progress in establishing a scalable foundation for profitable growth and shareholder value. The company aims to lead the shift to connected in-home healthcare, emphasizing its commitment to cost-effective patient care. AdaptHealth serves approx. 3.9 million patients annually, leveraging operational excellence and strategic acquisitions. The firm is focused on enhancing its chronic disease management programs and expanding its connected care offerings.
AdaptHealth Corp. (NASDAQ: AHCO) will host its first Capital Markets Day on September 16, 2022, at 9:00 a.m. ET. The event aims to present the Company’s business model, market position, and long-term strategies for growth and profitability. CEO Steve Griggs emphasizes the importance of connecting with investors and analysts. The event will be webcast live, with additional materials available on AdaptHealth’s website. This initiative reflects AdaptHealth's commitment to providing healthcare-at-home solutions and reaching approximately 3.9 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) reported second-quarter financial results for 2022, highlighting a net revenue of $727.6 million, a 17.9% increase from $617.0 million in 2021. Adjusted EBITDA rose 1.8% to $150.0 million, with an EBITDA margin improvement to 20.6%. However, net income dropped to $14.0 million from $79.1 million year-over-year. Non-acquired net revenue slightly decreased by 0.3%. The company maintained its 2022 guidance, projecting net revenue between $2.840 billion and $3.040 billion.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
